Literature DB >> 20354907

Antitumor activity of an adenovirus harboring human IL-24 in colon cancer.

Shujian Chang1, Jicheng Yang, Weichang Chen, Yufeng Xie, Weihua Sheng.   

Abstract

Data have increasingly shown that melanoma differentiation associated gene-7 (Mda-7/IL-24) has growth suppression activity and can induce apoptosis in many tumor cells, but to our knowledge there have been few studies about its role in colon cancer. We examined its anti-cancer effect on colon cancer. We constructed a recombinant replication-deficient adenovirus carrying human melanoma differentiation associated gene-7 (Ad-IL-24) and examined its apoptosis-inducing efficacy on the colon cancer HT-29 cell line and on an oxaliplatin-resistant cell line HT-29/oxa, using a combination of flow cytometry, growth suppressive activity by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and xenografts. Furthermore, we tested the suppression activity of Mda-7/IL-24 on vascular endothelial growth factor (VEGF) and microvessel density (MVD), as well as the inductive effect on expression of the growth arrest and DNA damage gene (GADD) in xenograft tumors by immunohistochemistry. Melanoma differentiation associated gene-7 can inhibit the growth of colon cancer cell lines and induced apoptosis in about (5.6±0.3)% of HT-29 cells (P<0.05). Xenograft growth was retarded in vivo in mice treated with melanoma differentiation associated gene-7, but the tumor proliferation rate for this group was not significantly different in comparison to controls (P>0.05). Furthermore, melanoma differentiation associated gene-7 induced expression of a growth arrest and DNA damage (GADD) gene and reduced the expression of both VEGF and MVD in xenograft tumors. This study supports a potential therapeutic effect for melanoma differentiation associated gene-7 on colon cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20354907     DOI: 10.1007/s11033-010-0121-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  21 in total

Review 1.  Mda-7, a novel melanoma differentiation associated gene with promise for cancer gene therapy.

Authors:  M T Madireddi; Z Z Su; C S Young; N I Goldstein; P B Fisher
Journal:  Adv Exp Med Biol       Date:  2000       Impact factor: 2.622

Review 2.  Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours.

Authors:  P B Vermeulen; G Gasparini; S B Fox; C Colpaert; L P Marson; M Gion; J A M Beliën; R M W de Waal; E Van Marck; E Magnani; N Weidner; A L Harris; L Y Dirix
Journal:  Eur J Cancer       Date:  2002-08       Impact factor: 9.162

Review 3.  Myeloid differentiation (MyD)/growth arrest DNA damage (GADD) genes in tumor suppression, immunity and inflammation.

Authors:  D A Liebermann; B Hoffman
Journal:  Leukemia       Date:  2002-04       Impact factor: 11.528

4.  Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients.

Authors:  J C Lee; N H Chow; S T Wang; S M Huang
Journal:  Eur J Cancer       Date:  2000-04       Impact factor: 9.162

5.  Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers.

Authors:  Maryla Krajewska; Hoguen Kim; Chul Kim; Haeyoun Kang; Kate Welsh; Shu-Ichi Matsuzawa; Michelle Tsukamoto; Ronald G Thomas; Nuria Assa-Munt; Zhe Piao; Koichi Suzuki; Manuel Perucho; Stan Krajewski; John C Reed
Journal:  Clin Cancer Res       Date:  2005-08-01       Impact factor: 12.531

6.  Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor.

Authors:  Rajagopal Ramesh; Abner M Mhashilkar; Fumihiro Tanaka; Yuji Saito; Cynthia D Branch; Kerry Sieger; John B Mumm; Alexis L Stewart; Amelie Boquoi; Laure Dumoutier; Elizabeth A Grimm; Jean-Christophe Renauld; Sergei Kotenko; Sunil Chada; Amelia Boquio
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

7.  Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression.

Authors:  H Jiang; J J Lin; Z Z Su; N I Goldstein; P B Fisher
Journal:  Oncogene       Date:  1995-12-21       Impact factor: 9.867

8.  mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK.

Authors:  Devanand Sarkar; Zao-Zhong Su; Irina V Lebedeva; Moira Sauane; Rahul V Gopalkrishnan; Kristoffer Valerie; Paul Dent; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-11       Impact factor: 11.205

9.  Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.

Authors:  Y Takahashi; Y Kitadai; C D Bucana; K R Cleary; L M Ellis
Journal:  Cancer Res       Date:  1995-09-15       Impact factor: 12.701

Review 10.  Interleukin-10 and related cytokines and receptors.

Authors:  Sidney Pestka; Christopher D Krause; Devanand Sarkar; Mark R Walter; Yufang Shi; Paul B Fisher
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

View more
  4 in total

1.  Cancer targeting gene-viro-therapy for pancreatic cancer using oncolytic adenovirus ZD55-IL-24 in immune-competent mice.

Authors:  Bin He; Xiuyan Huang; Xinyuan Liu; Bin Xu
Journal:  Mol Biol Rep       Date:  2013-05-11       Impact factor: 2.316

2.  Oncolytic Adenovirus Harboring Interleukin-24 Improves Chemotherapy for Advanced Prostate Cancer.

Authors:  Li-Jun Mao; Meng Ding; Kai Xu; Jun Pan; Haiyuan Yu; Chunhua Yang
Journal:  J Cancer       Date:  2018-10-22       Impact factor: 4.207

3.  Interleukin-24 Regulates T Cell Activity in Patients With Colorectal Adenocarcinoma.

Authors:  Yang Zhang; Ye Liu; Yuechao Xu
Journal:  Front Oncol       Date:  2019-12-10       Impact factor: 6.244

4.  The use of adenoviral vectors in gene therapy and vaccine approaches.

Authors:  Natália Meneses Araújo; Ileana Gabriela Sanchez Rubio; Nicholas Pietro Agulha Toneto; Mirian Galliote Morale; Rodrigo Esaki Tamura
Journal:  Genet Mol Biol       Date:  2022-10-07       Impact factor: 2.087

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.